These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 17414240)
1. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. Martenyi F; Brown EB; Caldwell CD J Clin Psychopharmacol; 2007 Apr; 27(2):166-70. PubMed ID: 17414240 [TBL] [Abstract][Full Text] [Related]
2. Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial. Martenyi F; Soldatenkova V Eur Neuropsychopharmacol; 2006 Jul; 16(5):340-9. PubMed ID: 16356696 [TBL] [Abstract][Full Text] [Related]
4. Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine. Malik ML; Connor KM; Sutherland SM; Smith RD; Davison RM; Davidson JR J Trauma Stress; 1999 Apr; 12(2):387-93. PubMed ID: 10378176 [TBL] [Abstract][Full Text] [Related]
5. Fluoxetine in posttraumatic stress disorder. van der Kolk BA; Dreyfuss D; Michaels M; Shera D; Berkowitz R; Fisler R; Saxe G J Clin Psychiatry; 1994 Dec; 55(12):517-22. PubMed ID: 7814344 [TBL] [Abstract][Full Text] [Related]
6. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression. Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208 [TBL] [Abstract][Full Text] [Related]
7. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. Spivak B; Strous RD; Shaked G; Shabash E; Kotler M; Weizman A J Clin Psychopharmacol; 2006 Apr; 26(2):152-6. PubMed ID: 16633143 [TBL] [Abstract][Full Text] [Related]
8. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. Davidson J; Baldwin DS; Stein DJ; Pedersen R; Ahmed S; Musgnung J; Benattia I; Rothbaum BO Int Clin Psychopharmacol; 2008 Sep; 23(5):299-303. PubMed ID: 18703940 [TBL] [Abstract][Full Text] [Related]
9. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. Black DW; Arndt S; Coryell WH; Argo T; Forbush KT; Shaw MC; Perry P; Allen J J Clin Psychopharmacol; 2007 Apr; 27(2):143-50. PubMed ID: 17414236 [TBL] [Abstract][Full Text] [Related]
10. Open trial of nefazodone for combat veterans with posttraumatic stress disorder. Garfield DA; Fichtner CG; Leveroni C; Mahableshwarkar A J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877 [TBL] [Abstract][Full Text] [Related]
11. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. Arch Gen Psychiatry; 1992 Feb; 49(2):139-47. PubMed ID: 1550466 [TBL] [Abstract][Full Text] [Related]
12. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults. Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936 [TBL] [Abstract][Full Text] [Related]
14. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. Davis LL; Davidson JR; Ward LC; Bartolucci A; Bowden CL; Petty F J Clin Psychopharmacol; 2008 Feb; 28(1):84-8. PubMed ID: 18204347 [TBL] [Abstract][Full Text] [Related]
15. Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study. Bahk WM; Pae CU; Tsoh J; Chae JH; Jun TY; Chul-Lee ; Kim KS Hum Psychopharmacol; 2002 Oct; 17(7):341-4. PubMed ID: 12415552 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder. Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. Lindley SE; Carlson EB; Hill K J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136 [TBL] [Abstract][Full Text] [Related]
18. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder. Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655 [TBL] [Abstract][Full Text] [Related]
19. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. Abolfazli R; Hosseini M; Ghanizadeh A; Ghaleiha A; Tabrizi M; Raznahan M; Golalizadeh M; Akhondzadeh S Depress Anxiety; 2011 Apr; 28(4):297-302. PubMed ID: 21456039 [TBL] [Abstract][Full Text] [Related]
20. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Hamner MB; Faldowski RA; Robert S; Ulmer HG; Horner MD; Lorberbaum JP Ann Clin Psychiatry; 2009; 21(2):89-94. PubMed ID: 19439158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]